Merck KGaA (MKKGY)
32.07
-0.37
(-1.14%)
USD |
OTCM |
Apr 25, 16:00
Merck Cash from Operations (TTM): 4.097B for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 4.097B |
September 30, 2023 | 4.197B |
June 30, 2023 | 4.298B |
March 31, 2023 | 4.465B |
December 31, 2022 | 4.492B |
September 30, 2022 | 4.519B |
June 30, 2022 | 4.728B |
March 31, 2022 | 4.939B |
December 31, 2021 | 5.462B |
September 30, 2021 | 5.621B |
June 30, 2021 | 5.384B |
March 31, 2021 | 4.867B |
December 31, 2020 | 3.971B |
September 30, 2020 | 3.349B |
June 30, 2020 | 2.932B |
March 31, 2020 | 3.207B |
December 31, 2019 | 3.197B |
September 30, 2019 | 3.309B |
June 30, 2019 | 3.114B |
March 31, 2019 | 2.713B |
December 31, 2018 | 2.620B |
September 30, 2018 | 2.357B |
June 30, 2018 | 2.519B |
March 31, 2018 | 2.692B |
December 31, 2017 | 3.053B |
Date | Value |
---|---|
September 30, 2017 | 3.271B |
June 30, 2017 | 3.465B |
March 31, 2017 | 3.226B |
December 31, 2016 | 2.787B |
September 30, 2016 | 2.726B |
June 30, 2016 | 2.516B |
March 31, 2016 | 2.509B |
December 31, 2015 | 2.436B |
September 30, 2015 | 3.166B |
June 30, 2015 | 3.117B |
March 31, 2015 | 3.353B |
December 31, 2014 | 3.598B |
September 30, 2014 | 2.662B |
June 30, 2014 | 2.854B |
March 31, 2014 | 2.835B |
December 31, 2013 | 2.956B |
September 30, 2013 | 2.952B |
June 30, 2013 | 2.933B |
March 31, 2013 | 3.240B |
December 31, 2012 | 3.178B |
September 30, 2012 | 2.646B |
June 30, 2012 | 2.438B |
March 31, 2012 | 2.001B |
December 31, 2011 | 1.772B |
September 30, 2011 | 2.400B |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
2.932B
Minimum
Jun 2020
5.621B
Maximum
Sep 2021
4.218B
Average
4.298B
Median
Jun 2023
Cash from Operations (TTM) Benchmarks
Affimed NV | -119.38M |
InflaRx NV | -40.94M |
MorphoSys AG | -- |
BioNTech SE | 5.815B |
Immatics NV | 19.73M |